Notice of upcoming COVID-19 research funding opportunity

CIHR, in partnership with Health Canada and the Public Health Agency of Canada, would like to provide information to the research community on an upcoming rapid funding opportunity that is part of the Government of Canada's continued response to address the health challenges of the COVID-19 pandemic. The Operating Grant: COVID-19 Outpatient Therapeutic Study competition will launch the week of May 2, 2022.

We are providing preliminary information to allow the research community to prepare and respond to an expedited process.

Operating Grant: COVID-19 Outpatient Therapeutic Study

Canada has invested substantially in COVID-19 therapeutics alongside its portfolio of vaccines, screening approaches, and broader public health measures. Toward the end of 2021, the Government of Canada announced purchase agreements to access emerging antiviral medications as treatment options for patients who present with mild to moderate COVID-19 and who are at high risk of developing serious disease. To effectively roll out these new antiviral medications, there is a pressing need to further study the outcomes, including effectiveness, comparative effectiveness, and cost effectiveness of administering these treatments - as well as any other treatments which may become available - to non-hospitalized patients in the Canadian health care system. This funding opportunity is also intended to support research conducted across multiple provinces and territories and/or regions to ensure appropriate pan-Canadian representation and collaboration to achieve set outcomes.

Objectives

The specific objectives of this funding opportunity are to:

Key Design Components

Applications must incorporate all of the following key design components:

Availability of Funds

The Government of Canada's financial contributions are subject to availability of funds. This amount may increase if additional funding partners participate. Should the Government of Canada funding levels not be available or are decreased due to unforeseen circumstances, the Government of Canada reserves the right to reduce, defer or suspend financial contributions to grants received as a result of this funding opportunity.

Expression of Interest (EOI)

A collaboration call will be scheduled on May 9, 2022, at 2pm ET, to explore collaborations across teams with the aim of maximizing the reach and impact of the research.

Requirements for the application process will be outlined in the Funding Opportunity.

Anticipated timelines

These dates are estimates and subject to change.

Peer Review Recruitment

Recruitment for peer reviewers will begin immediately, and international reviewers are welcomed. If you are interested and available to volunteer as a peer reviewer, please reach out to CIHR at CTFPeerReview-FECEvaluationparlespairs@cihr-irsc.gc.ca

Contact Information

For general inquiries please contact:

CIHR Contact Centre
Telephone: 613-954-1968
Toll Free: 1-888-603-4178
support-soutien@cihr-irsc.gc.ca

Disclaimer

The information contained herein is anticipatory only and does not represent an official funding commitment by the Canadian Institutes of Health Research. Accordingly, the information contained herein may differ from the official funding opportunity, if and when, that will be published on ResearchNet.

Date modified: